IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE

The present application relates to an imidazolinone derivative and the use thereof in medicine, and specifically relates to a pyrimidine derivative as represented by general formula (I), or a stereoisomer, solvate, metabolite, prodrug, pharmaceutically acceptable salt or co-crystal thereof, a pharma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YAN Jie, HE Lvxue, XU Xuezhen, LEI Feiquan, HE Yang, SUN Yi, SU Guizhuan, WEI Yonggang, CHU Hongzhu, LIU Bing, WANG Meiwei
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YAN Jie
HE Lvxue
XU Xuezhen
LEI Feiquan
HE Yang
SUN Yi
SU Guizhuan
WEI Yonggang
CHU Hongzhu
LIU Bing
WANG Meiwei
description The present application relates to an imidazolinone derivative and the use thereof in medicine, and specifically relates to a pyrimidine derivative as represented by general formula (I), or a stereoisomer, solvate, metabolite, prodrug, pharmaceutically acceptable salt or co-crystal thereof, a pharmaceutical composition containing same and the use of the compound or the composition of the present application in the preparation of drugs for treating cancers. La presente solicitud se relaciona con derivados de imidazolidinona y su uso médico, y en particular se relaciona con derivados de pirimidina representados por la fórmula general (I), o estereoisómeros, solvatos, metabolitos, profármacos, sales farmacéuticamente aceptables o cocristales de los mismos, una composición farmacéutica que comprende éstos, y el uso del compuesto o composición farmacéutica según la presente solicitud en la fabricación de un medicamento para el tratamiento del cáncer. (ver Fórmula).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2022013054A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2022013054A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2022013054A3</originalsourceid><addsrcrecordid>eNrjZDDx9PV0cYzy9_H08_dzVXBxDfIMcwzxDHNVcPRzUQgNdlUI8XANcvV3U_D0U_B1dfF09vRz5WFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8b4RRgZGRgaGxgamJo7GRCkCAA7PJ7I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE</title><source>esp@cenet</source><creator>YAN Jie ; HE Lvxue ; XU Xuezhen ; LEI Feiquan ; HE Yang ; SUN Yi ; SU Guizhuan ; WEI Yonggang ; CHU Hongzhu ; LIU Bing ; WANG Meiwei</creator><creatorcontrib>YAN Jie ; HE Lvxue ; XU Xuezhen ; LEI Feiquan ; HE Yang ; SUN Yi ; SU Guizhuan ; WEI Yonggang ; CHU Hongzhu ; LIU Bing ; WANG Meiwei</creatorcontrib><description>The present application relates to an imidazolinone derivative and the use thereof in medicine, and specifically relates to a pyrimidine derivative as represented by general formula (I), or a stereoisomer, solvate, metabolite, prodrug, pharmaceutically acceptable salt or co-crystal thereof, a pharmaceutical composition containing same and the use of the compound or the composition of the present application in the preparation of drugs for treating cancers. La presente solicitud se relaciona con derivados de imidazolidinona y su uso médico, y en particular se relaciona con derivados de pirimidina representados por la fórmula general (I), o estereoisómeros, solvatos, metabolitos, profármacos, sales farmacéuticamente aceptables o cocristales de los mismos, una composición farmacéutica que comprende éstos, y el uso del compuesto o composición farmacéutica según la presente solicitud en la fabricación de un medicamento para el tratamiento del cáncer. (ver Fórmula).</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221109&amp;DB=EPODOC&amp;CC=MX&amp;NR=2022013054A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221109&amp;DB=EPODOC&amp;CC=MX&amp;NR=2022013054A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAN Jie</creatorcontrib><creatorcontrib>HE Lvxue</creatorcontrib><creatorcontrib>XU Xuezhen</creatorcontrib><creatorcontrib>LEI Feiquan</creatorcontrib><creatorcontrib>HE Yang</creatorcontrib><creatorcontrib>SUN Yi</creatorcontrib><creatorcontrib>SU Guizhuan</creatorcontrib><creatorcontrib>WEI Yonggang</creatorcontrib><creatorcontrib>CHU Hongzhu</creatorcontrib><creatorcontrib>LIU Bing</creatorcontrib><creatorcontrib>WANG Meiwei</creatorcontrib><title>IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE</title><description>The present application relates to an imidazolinone derivative and the use thereof in medicine, and specifically relates to a pyrimidine derivative as represented by general formula (I), or a stereoisomer, solvate, metabolite, prodrug, pharmaceutically acceptable salt or co-crystal thereof, a pharmaceutical composition containing same and the use of the compound or the composition of the present application in the preparation of drugs for treating cancers. La presente solicitud se relaciona con derivados de imidazolidinona y su uso médico, y en particular se relaciona con derivados de pirimidina representados por la fórmula general (I), o estereoisómeros, solvatos, metabolitos, profármacos, sales farmacéuticamente aceptables o cocristales de los mismos, una composición farmacéutica que comprende éstos, y el uso del compuesto o composición farmacéutica según la presente solicitud en la fabricación de un medicamento para el tratamiento del cáncer. (ver Fórmula).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDx9PV0cYzy9_H08_dzVXBxDfIMcwzxDHNVcPRzUQgNdlUI8XANcvV3U_D0U_B1dfF09vRz5WFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8b4RRgZGRgaGxgamJo7GRCkCAA7PJ7I</recordid><startdate>20221109</startdate><enddate>20221109</enddate><creator>YAN Jie</creator><creator>HE Lvxue</creator><creator>XU Xuezhen</creator><creator>LEI Feiquan</creator><creator>HE Yang</creator><creator>SUN Yi</creator><creator>SU Guizhuan</creator><creator>WEI Yonggang</creator><creator>CHU Hongzhu</creator><creator>LIU Bing</creator><creator>WANG Meiwei</creator><scope>EVB</scope></search><sort><creationdate>20221109</creationdate><title>IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE</title><author>YAN Jie ; HE Lvxue ; XU Xuezhen ; LEI Feiquan ; HE Yang ; SUN Yi ; SU Guizhuan ; WEI Yonggang ; CHU Hongzhu ; LIU Bing ; WANG Meiwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2022013054A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YAN Jie</creatorcontrib><creatorcontrib>HE Lvxue</creatorcontrib><creatorcontrib>XU Xuezhen</creatorcontrib><creatorcontrib>LEI Feiquan</creatorcontrib><creatorcontrib>HE Yang</creatorcontrib><creatorcontrib>SUN Yi</creatorcontrib><creatorcontrib>SU Guizhuan</creatorcontrib><creatorcontrib>WEI Yonggang</creatorcontrib><creatorcontrib>CHU Hongzhu</creatorcontrib><creatorcontrib>LIU Bing</creatorcontrib><creatorcontrib>WANG Meiwei</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAN Jie</au><au>HE Lvxue</au><au>XU Xuezhen</au><au>LEI Feiquan</au><au>HE Yang</au><au>SUN Yi</au><au>SU Guizhuan</au><au>WEI Yonggang</au><au>CHU Hongzhu</au><au>LIU Bing</au><au>WANG Meiwei</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE</title><date>2022-11-09</date><risdate>2022</risdate><abstract>The present application relates to an imidazolinone derivative and the use thereof in medicine, and specifically relates to a pyrimidine derivative as represented by general formula (I), or a stereoisomer, solvate, metabolite, prodrug, pharmaceutically acceptable salt or co-crystal thereof, a pharmaceutical composition containing same and the use of the compound or the composition of the present application in the preparation of drugs for treating cancers. La presente solicitud se relaciona con derivados de imidazolidinona y su uso médico, y en particular se relaciona con derivados de pirimidina representados por la fórmula general (I), o estereoisómeros, solvatos, metabolitos, profármacos, sales farmacéuticamente aceptables o cocristales de los mismos, una composición farmacéutica que comprende éstos, y el uso del compuesto o composición farmacéutica según la presente solicitud en la fabricación de un medicamento para el tratamiento del cáncer. (ver Fórmula).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2022013054A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAN%20Jie&rft.date=2022-11-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2022013054A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true